乐普基因品牌怎么样 申请店铺

北京乐普基因科技股份有限公司（乐普基因）以及全资控股的北京爱普益医学检验中心是一家以心血管分子诊断和高通量基因测序为核心平台，涵盖试剂研发、销售以及第三方医学检验的产业链平台型新三板上市公司，乐普基因股票于2016年2月29日起在全国中小企业股份转让系统挂牌公开转让。

自2014年11月乐普医疗控股北京爱普益医学检验中心介入实际运营，经过近一年的融合发展，乐普基因在全资子公司北京爱普益医学检验中心原有的基础检验业务的基础上，通过乐普医疗集团在心血管领域的品牌优势和在高通量测序和分子诊断领域的研发优势，目前已初步形成第三方医学基础检测服务、高通量基因测序服务和心血管分子诊断试剂的研发销售三大版块。

Beijing Lepu Gene Technology Co., Ltd. (Lepu gene) and Beijing aipuyi medical testing center, a wholly-owned holding company, are new three board listed companies with the core platform of cardiovascular molecular diagnosis and high-throughput gene sequencing, covering reagent research and development, sales and third-party medical testing. Lepu gene shares have been listed in small and medium-sized enterprises in China since February 29, 2016 The share transfer system is listed for public transfer. Since November 2014, Lepu medical holding Beijing aipuyi medical testing center has been involved in the actual operation. After nearly a year of integrated development, Lepu gene, based on the original basic testing business of Beijing aipuyi medical testing center, a wholly-owned subsidiary of Lepu medical group, has passed Lepu medical group's brand advantages in the field of cardiovascular and research and development advantages in the field of high-throughput sequencing and molecular diagnosis. At present It has initially formed three major areas of research, development and sales of third-party medical basic testing services, high-throughput gene sequencing services and cardiovascular molecular diagnostic reagents.

本文链接： https://brand.waitui.com/00ffb038d.html 联系电话：01059773721